Zogenix Inc. (ZGNX) Has Broken Out To A New High On Study Results

Zogenix Inc. (ZGNX) announced Thursday morning that its second Phase 3 study of ZX008 met the primary endpoint and all key secondary endpoints.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>